Table 3.
Clinical management of patients with COVID-2019.
| Duration from admission to discharge | All patients (N = 260) |
|---|---|
| Definitions of severe patients | |
| Respiratory rate > 30/min | 209 (80.4%) |
| Mean oxygen saturation < 93% | 185 (71.2%) |
| PaO2/FiO2 ≤ 300 mmHg | 79 (30.4%) |
| Lung lesion progression > 50% within 24-48 h | 16 (6.2%) |
| Treatment | |
| Antiviral therapy | 260 (100%) |
| Antibiotic therapy | 260 (100%) |
| Use of corticosteroid | 103 (39.6%) |
| Oxygen support | |
| Nasal catheter | 176 (67.7%) |
| Mask oxygen | 84 (32.3%) |
| High-flow nasal cannula | 113 (43.5%) |
| Assisting ventilation | |
| Bipap | 47 (18.1%) |
| Invasive mechanical ventilation | 12 (4.6%) |
| Outcome | |
| Discharge | 183 (70.4%) |
| Continue to be hospitalized | 35 (13.5%) |
| ICU | 17 (6.5%) |
| Death | 25 (9.6%) |